1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for the United
States Biopharmaceutical Fermentation Systems Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in the United
States Biopharmaceutical Fermentation Systems Market
4.
United States Biopharmaceutical
Fermentation Systems Market by Product
4.1.
Upstream Process Product
4.1.1. Bioreactors/Fermenters
4.1.2. Process Monitoring Systems
4.1.3. Media and Culture Preparation
4.1.4. Buffers
4.1.5. Other Upstream Products
4.2.
Downstream Process Products
4.2.1. Filtration and Separation Instruments
4.2.2. Chromatography Systems
4.2.3. Consumables and Accessories
4.2.4. Other Downstream Products
5.
United States Biopharmaceutical
Fermentation Systems Market by Application
5.1.
Antibiotics
5.2.
Monoclonal Antibodies
5.3.
Recombinant Proteins
5.4.
Probiotics
5.5.
Other Applications
6.
United States Biopharmaceutical
Fermentation Systems Market by End User
6.1.
Biopharmaceutical Companies
6.2.
Contract Research Organizations
6.3.
Research and Development
Institutes
6.4.
Food Industry
6.5.
Other End Users
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for the United
States Biopharmaceutical Fermentation Systems Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in the United
States Biopharmaceutical Fermentation Systems Market
4.
United States Biopharmaceutical
Fermentation Systems Market by Product
4.1.
Upstream Process Product
4.1.1. Bioreactors/Fermenters
4.1.2. Process Monitoring Systems
4.1.3. Media and Culture Preparation
4.1.4. Buffers
4.1.5. Other Upstream Products
4.2.
Downstream Process Products
4.2.1. Filtration and Separation Instruments
4.2.2. Chromatography Systems
4.2.3. Consumables and Accessories
4.2.4. Other Downstream Products
5.
United States Biopharmaceutical
Fermentation Systems Market by Application
5.1.
Antibiotics
5.2.
Monoclonal Antibodies
5.3.
Recombinant Proteins
5.4.
Probiotics
5.5.
Other Applications
6.
United States Biopharmaceutical
Fermentation Systems Market by End User
6.1.
Biopharmaceutical Companies
6.2.
Contract Research Organizations
6.3.
Research and Development
Institutes
6.4.
Food Industry
6.5.
Other End Users
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10